Division of General Pediatrics, Department of Pediatrics and Adolescent Medicine.
Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz.
J Pediatr Gastroenterol Nutr. 2022 Jan 1;74(1):e1-e7. doi: 10.1097/MPG.0000000000003299.
Klebsiella oxytoca is a gastrointestinal pathobiont with the potential to produce the toxins tilivalline and tilimycin, which cause antibiotic-associated hemorrhagic colitis. Overgrowth of toxigenic K oxytoca has recently been implicated in necrotizing enterocolitis. K oxytoca colonizes 2-9% of healthy adults, however, there is no systematic data on colonization in healthy children. We investigated K oxytoca colonization and its toxigenic properties in healthy infants.
We sampled stool of healthy infants and determined K oxytoca colonization using stool culture and PCR (pehX). Toxin in stool was measured with HPLC/high-resolution mass spectrometry. K oxytoca isolates were typed using multi-locus sequence typing (MLST) and K oxytoca toxin PCR (npsA/B). Cytotoxin production of isolates was analyzed by MTT assay.
K oxytoca was detected in 30 of 61 infants (49%) using stool culture and in 45 of 61 (73%) using PCR (pehX). Toxin marker PCR (npsA/B) was positive in 66% of stool samples positive for K oxytoca PCR. Stool toxin levels were too low for quantitation but traces of tilivalline were detected. Contrarily, 49% of K oxytoca isolates demonstrated toxicity in the MTT assay. MLST revealed 36 distinct sequence types affiliated with all known K oxytoca sequence type clusters (A, B1 and B2).
More than 70% of healthy infants were colonized with K oxytoca. Toxin quantities in stool of colonized healthy infants were below detection level, yet half of the isolates produced toxin in vitro demonstrating their pathobiont potential. The high occurrence of toxigenic K oxytoca in healthy infants has to be considered for future disease association studies.
产酸克雷伯氏菌是胃肠道共生菌,具有产生 tilivalline 和 tilimycin 毒素的潜力,这两种毒素可引起抗生素相关性出血性结肠炎。产毒产酸克雷伯氏菌的过度生长最近与坏死性小肠结肠炎有关。产酸克雷伯氏菌定植于 2-9%的健康成年人,但在健康儿童中,其定植情况尚无系统数据。我们研究了健康婴儿中产酸克雷伯氏菌的定植及其产毒特性。
我们采集了健康婴儿的粪便样本,使用粪便培养和 PCR(pehX)检测产酸克雷伯氏菌的定植情况。采用 HPLC/高分辨率质谱法测定粪便中的毒素。采用多位点序列分型(MLST)和产酸克雷伯氏菌毒素 PCR(npsA/B)对产酸克雷伯氏菌分离株进行分型。通过 MTT 测定分析分离株的细胞毒素产生情况。
使用粪便培养检测到 61 名婴儿中有 30 名(49%)存在产酸克雷伯氏菌,使用 PCR(pehX)检测到 45 名(73%)存在产酸克雷伯氏菌。PCR(npsA/B)检测到 66%的产酸克雷伯氏菌 PCR 阳性粪便样本呈阳性。粪便毒素水平过低无法定量,但检测到微量的 tilivalline。相反,49%的产酸克雷伯氏菌分离株在 MTT 测定中表现出毒性。MLST 显示 36 个不同的序列类型,与所有已知的产酸克雷伯氏菌序列型簇(A、B1 和 B2)有关。
超过 70%的健康婴儿定植了产酸克雷伯氏菌。定植于健康婴儿粪便中的毒素量低于检测水平,但半数分离株在体外产生毒素,表明其具有潜在的病原菌特性。健康婴儿中产毒产酸克雷伯氏菌的高发生率需要在未来的疾病相关性研究中加以考虑。